Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Caroline Toudic, Amandine Vargas, Yong Xiao, Guillaume St-Pierre, Norbert Bannert, Julie Lafond, Éric Rassart, Sachiko Sato, Benoit Barbeau
Author Information
  1. Caroline Toudic: Département des Sciences Biologiques, Centre de Recherche BioMed, Université du Quebec à Montréal, Montreal, Quebec, Canada.
  2. Amandine Vargas: Département des Sciences Biologiques, Centre de Recherche BioMed, Université du Quebec à Montréal, Montreal, Quebec, Canada.
  3. Yong Xiao: Département des Sciences Biologiques, Centre de Recherche BioMed, Université du Quebec à Montréal, Montreal, Quebec, Canada.
  4. Guillaume St-Pierre: Glycobiology and Bioimaging Laboratory, Research Centre for Infectious Diseases, Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.
  5. Norbert Bannert: Robert-Koch Institute, Berlin, Germany.
  6. Julie Lafond: Département des Sciences Biologiques, Centre de Recherche BioMed, Université du Quebec à Montréal, Montreal, Quebec, Canada.
  7. Éric Rassart: Département des Sciences Biologiques, Centre de Recherche BioMed, Université du Quebec à Montréal, Montreal, Quebec, Canada.
  8. Sachiko Sato: Glycobiology and Bioimaging Laboratory, Research Centre for Infectious Diseases, Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.
  9. Benoit Barbeau: Département des Sciences Biologiques, Centre de Recherche BioMed, Université du Quebec à Montréal, Montreal, Quebec, Canada.

Abstract

Syncytin (Syn)-2 is an important fusogenic protein that contributes to the formation of the placental syncytiotrophoblast. Galectin (Gal)-1, a soluble lectin, is also involved in trophoblast cell fusion and modulates the interaction of certain retroviral envelopes with their cellular receptor. This study aimed to investigate the association between Syn-2 and Gal-1 during human trophoblast cell fusion. This association was evaluated on primary villous cytotrophoblasts (vCTBs) and cell lines using recombinant Gal-1 and Syn-2-pseudotyped viruses. Using lactose, a Gal antagonist, and Gal-1-specific small interfering RNA (siRNA) transfections, we confirmed the implication of Gal-1 in vCTBs and BeWo cell fusion, although RT-PCR and ELISA analyses suggested that Gal-1 alone did not induce syncytialization. Infection assays showed a specific and significant effect of Gal-1 on the infectivity of Syn-2-pseudotyped viruses that depended on the expression of major facilitator superfamily domain-containing 2A (MFSD2a). Moreover, Gal-3, another placental Gal, did not modulate the infectivity of Syn-2-positive viruses, strengthening the specific association between Gal-1 and Syn-2. Interestingly, Gal-1 significantly reduced the infectivity of Syn-1-pseudotyped viruses, suggesting the opposite effects of Gal-1 on Syn-1 and -2. Finally, coimmunoprecipitation experiments showed a glycan-dependent interaction between Syn-2-bearing virions and Gal-1. We conclude that Gal-1 specifically interacts with Syn-2 and possibly regulates Syn-2/MFSD2a interaction during syncytialization of trophoblastic cells.-Toudic, C., Vargas, A., Xiao, Y., St-Pierre, G., Bannert, N., Lafond, J., Rassart, É., Sato, S., Barbeau, B. Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Keywords

References

  1. Hum Reprod. 1998 Mar;13(3):730-5 [PMID: 9572443]
  2. J Mol Biol. 2009 Sep 18;392(2):301-18 [PMID: 19616006]
  3. Hypertens Res. 2018 Jan;41(1):45-52 [PMID: 28978981]
  4. J Virol. 2005 May;79(9):5585-93 [PMID: 15827173]
  5. Cell Signal. 2013 Apr;25(4):1027-35 [PMID: 23333240]
  6. Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11756-65 [PMID: 21677192]
  7. J Virol. 2008 Feb;82(3):1107-17 [PMID: 18032515]
  8. Development. 1992 May;115(1):143-55 [PMID: 1638977]
  9. Am J Physiol Cell Physiol. 2010 Jun;298(6):C1517-26 [PMID: 20200207]
  10. Biol Reprod. 2008 Nov;79(5):815-23 [PMID: 18650494]
  11. Placenta. 1997 Jul-Aug;18(5-6):433-9 [PMID: 9250706]
  12. AIDS Res Hum Retroviruses. 2003 Oct;19(10):857-64 [PMID: 14585217]
  13. J Biol Chem. 2002 Dec 20;277(51):50062-8 [PMID: 12397062]
  14. Placenta. 2005 Aug;26(7):556-62 [PMID: 15993705]
  15. Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17532-7 [PMID: 18988732]
  16. Virology. 2008 Feb 5;371(1):121-9 [PMID: 18028978]
  17. Glycobiology. 2012 Oct;22(10):1374-86 [PMID: 22752006]
  18. Hum Reprod Update. 2014 Mar-Apr;20(2):175-93 [PMID: 24077937]
  19. J Biol Chem. 2003 May 2;278(18):15832-41 [PMID: 12604606]
  20. Mol Cell Biol. 2003 May;23(10):3566-74 [PMID: 12724415]
  21. Methods Enzymol. 2010;480:267-94 [PMID: 20816214]
  22. Dev Dyn. 1995 Jun;203(2):241-51 [PMID: 7655085]
  23. J Virol. 2011 Nov;85(22):11742-51 [PMID: 21880749]
  24. Am J Reprod Immunol. 2013 Apr;69(4):369-82 [PMID: 23406009]
  25. PLoS Genet. 2013 Mar;9(3):e1003400 [PMID: 23555306]
  26. J Virol. 2015 Mar;89(5):2520-9 [PMID: 25505064]
  27. Nature. 2000 Feb 17;403(6771):785-9 [PMID: 10693809]
  28. Mol Cell Proteomics. 2016 Jun;15(6):1857-66 [PMID: 26929217]
  29. FASEB J. 2014 Aug;28(8):3703-19 [PMID: 24812088]
  30. Histochem Cell Biol. 2004 Jun;121(6):501-8 [PMID: 15221419]
  31. Cell Adh Migr. 2016 Mar 3;10(1-2):28-38 [PMID: 26418280]
  32. Nat Med. 2007 Dec;13(12):1450-7 [PMID: 18026113]
  33. Exp Cell Res. 1990 Feb;186(2):306-16 [PMID: 2153559]
  34. Apoptosis. 2007 Jan;12(1):37-43 [PMID: 17080327]
  35. Retrovirology. 2008 Nov 25;5:105 [PMID: 19032754]
  36. Cell Adh Migr. 2016 Mar 3;10(1-2):39-55 [PMID: 26853155]
  37. Mol Cancer. 2010 Mar 17;9:62 [PMID: 20236515]
  38. Nucleic Acids Res. 2008 Jun;36(11):3834-46 [PMID: 18495750]
  39. Reprod Sci. 2011 Nov;18(11):1085-91 [PMID: 21493955]
  40. Placenta. 2007 Nov-Dec;28(11-12):1165-73 [PMID: 17664004]
  41. Placenta. 2007 Feb-Mar;28(2-3):185-91 [PMID: 16714059]
  42. Int J Mol Sci. 2016 Apr 28;17(5): [PMID: 27136536]
  43. Placenta. 2012 Nov;33(11):933-41 [PMID: 22999499]
  44. Histochem Cell Biol. 2006 Oct;126(4):437-44 [PMID: 16607538]
  45. Methods Mol Biol. 2009;550:73-87 [PMID: 19495697]
  46. J Immunol. 2013 Jan 15;190(2):630-40 [PMID: 23241887]
  47. Pathog Dis. 2017 Jul 31;75(5): [PMID: 28449072]
  48. PLoS One. 2015 Mar 17;10(3):e0121468 [PMID: 25781974]
  49. J Virol. 2003 Mar;77(5):2936-45 [PMID: 12584318]
  50. Endocrinology. 1986 Apr;118(4):1567-82 [PMID: 3512258]
  51. Placenta. 2013 Jan;34(1):85-8 [PMID: 23177091]
  52. Cell Rep. 2017 Oct 31;21(5):1150-1159 [PMID: 29091755]
  53. Placenta. 2010 Sep;31(9):825-32 [PMID: 20656349]
  54. J Cell Sci. 2003 Aug 15;116(Pt 16):3413-21 [PMID: 12840075]
  55. Placenta. 2015 Apr;36 Suppl 1:S35-42 [PMID: 25564303]
  56. Mol Hum Reprod. 2013 Jan;19(1):43-53 [PMID: 23002109]
  57. Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S115-22 [PMID: 26428489]
  58. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13013-8 [PMID: 14557543]
  59. Biol Reprod. 2019 Jul 18;:null [PMID: 31318021]
  60. Mol Hum Reprod. 2011 Dec;17(12):747-57 [PMID: 21831883]
  61. J Virol. 2002 Jul;76(13):6442-52 [PMID: 12050356]
  62. Placenta. 2009 Jun;30(6):547-50 [PMID: 19345995]
  63. J Virol. 2004 Jan;78(2):1050-4 [PMID: 14694139]
  64. Dev Biol. 2003 May 1;257(1):41-54 [PMID: 12710956]
  65. Viruses. 2014 Nov 24;6(11):4609-27 [PMID: 25421890]
  66. Placenta. 2009 Dec;30(12):1078-82 [PMID: 19900702]
  67. J Virol. 2009 Jul;83(14):6995-7003 [PMID: 19403677]
  68. Eur J Immunol. 1994 Jan;24(1):216-21 [PMID: 8020558]
  69. J Immunol. 2005 Apr 1;174(7):4120-6 [PMID: 15778371]
  70. Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11451-6 [PMID: 23798433]
  71. J Biol Chem. 2004 Dec 17;279(51):52949-60 [PMID: 15466412]
  72. Glycobiology. 1999 Oct;9(10):979-84 [PMID: 10521533]
  73. Methods Mol Biol. 2015;1207:397-420 [PMID: 25253155]
  74. Mol Cell Endocrinol. 2016 Jan 15;420:180-93 [PMID: 26586208]
  75. J Immunol. 2002 Feb 15;168(4):1813-22 [PMID: 11823514]
  76. Biochim Biophys Acta. 2002 Sep 19;1572(2-3):232-54 [PMID: 12223272]
  77. Cell Mol Life Sci. 2014 Aug;71(16):3151-64 [PMID: 24413738]
  78. J Cell Biochem. 2008 Oct 15;105(3):766-75 [PMID: 18712755]
  79. Glycobiology. 1993 Aug;3(4):297-304 [PMID: 8400545]
  80. J Matern Fetal Neonatal Med. 2008 Jul;21(7):429-42 [PMID: 18570123]
  81. Placenta. 2013 Oct;34(10):863-72 [PMID: 23911101]
  82. J Gen Virol. 2006 Jul;87(Pt 7):2067-71 [PMID: 16760410]
  83. Adv Exp Med Biol. 2011;713:81-95 [PMID: 21432015]
  84. Histol Histopathol. 2016 Oct;31(10):1095-111 [PMID: 26901464]
  85. FEBS J. 2007 Jun;274(11):2715-27 [PMID: 17451431]

Grants

  1. MOP130561/CIHR

MeSH Term

Cell Fusion
Endogenous Retroviruses
Female
Galectin 1
HEK293 Cells
HeLa Cells
Humans
Pregnancy
Pregnancy Proteins
Protein Binding
Trophoblasts

Chemicals

ERVFRD-1 protein, human
Galectin 1
Pregnancy Proteins

Word Cloud

Created with Highcharts 10.0.0Gal-1fusiontrophoblastcellvirusesproteinGalinteractionretroviralassociationSyn-2humansyncytializationinfectivityinteracts-2placentallectinvillouscytotrophoblastsvCTBsSyn-2-pseudotypedshowedspecificGalectin-1endogenousenvelopesyncytin-2potentiateshumansSyncytinSynimportantfusogeniccontributesformationsyncytiotrophoblastGalectin-1solublealsoinvolvedmodulatescertainenvelopescellularreceptorstudyaimedinvestigateevaluatedprimarylinesusingrecombinantUsinglactoseantagonistGal-1-specificsmallinterferingRNAsiRNAtransfectionsconfirmedimplicationBeWoalthoughRT-PCRELISAanalysessuggestedaloneinduceInfectionassayssignificanteffectdependedexpressionmajorfacilitatorsuperfamilydomain-containing2AMFSD2aMoreoverGal-3anothermodulateSyn-2-positivestrengtheningInterestinglysignificantlyreducedSyn-1-pseudotypedsuggestingoppositeeffectsSyn-1Finallycoimmunoprecipitationexperimentsglycan-dependentSyn-2-bearingvirionsconcludespecificallypossiblyregulatesSyn-2/MFSD2atrophoblasticcells-ToudicCVargasAXiaoYSt-PierreGBannertNLafondJRassartÉSatoSBarbeauBERVFRD-1β-galactoside-binding

Similar Articles

Cited By